River Renal
United States · $10.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Total Funding
- $10.0M
- Last Round
- $10.0M Seed
- Rounds
- 1
About
River Renal develops novel drugs for kidney diseases with high unmet medical needs, backed by Bain Capital Life Sciences.
Summary
River Renal is a Biotech company based in United States. It has raised $10.0M in total across 1 round. Investors include Roche, Bain Capital Life Sciences and HBM Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...